Tech Healthcare Sector

Matinas BioPharma Holdings

Market Cap: US$4.4m

A clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.

Bounce Mobile Systems

Market Cap: US$4.4m

Delex Healthcare Group, Inc. engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.

Fuse Medical

Market Cap: US$4.4m

Manufactures and distributes medical devices in the United States.

TrivarX

Market Cap: AU$6.8m

A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.

Filament Health

Market Cap: US$4.4m

Operates as a clinical-stage natural psychedelic drug development company in Canada.

Dogecoin Cash

Market Cap: US$4.4m

Through its subsidiaries, provides telemedicine online referral services for customers desiring medical marijuana cards in the United States.

Applied DNA Sciences

Market Cap: US$4.4m

A biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally.

Raphael Pharmaceutical

Market Cap: US$4.4m

A pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids.

Avricore Health

Market Cap: CA$6.1m

Engages in the health data and point-of-care technologies business.

Visionflex Group

Market Cap: AU$6.7m

Together its subsidiaries, engages in the provision of healthcare and corporate online search and appointment booking services in Australia.

Adial Pharmaceuticals

Market Cap: US$4.3m

A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.

Indiva

Market Cap: CA$5.9m

Engages in the production, processing, and sale of cannabis and cannabis related products in Canada.

Centogene

Market Cap: US$4.3m

Provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific.

Aptose Biosciences

Market Cap: CA$6.0m

A clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States.

Mitesco

Market Cap: US$4.3m

Provides cloud computing, application hosting, and other data center related applications.

Dermata Therapeutics

Market Cap: US$4.3m

A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications.

Oragenics

Market Cap: US$4.3m

A development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States.

Encision

Market Cap: US$4.3m

A medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States.

Titan Pharmaceuticals

Market Cap: US$4.3m

Does not have significant operations.

KMA Holding

Market Cap: US$4.2m

Through its subsidiaries, manufactures human and pet home medical test kits and emergency response mobile hospital units in the United States.

Quest PharmaTech

Market Cap: CA$5.9m

A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.

ViaDerma

Market Cap: US$4.2m

Operates as a specialty pharmaceutical company in the United States.

Ayurcann Holdings

Market Cap: CA$5.8m

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

Nu-Med Plus

Market Cap: US$4.2m

A medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide.

Optimus Healthcare Services

Market Cap: US$4.2m

Provides community-based oncology practices with the necessary infrastructure and support to enroll their patients on clinical trials in the United States.

Sweet Earth Holdings

Market Cap: CA$5.8m

Does not have significant operations.

ARCpoint

Market Cap: CA$5.8m

Provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States.

Nuwellis

Market Cap: US$4.1m

A medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.

Azitra

Market Cap: US$4.0m

An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

Invion

Market Cap: AU$6.3m

A clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia.

Aclarion

Market Cap: US$4.0m

Operates as a healthcare technology company in the United States.

Vycor Medical

Market Cap: US$4.0m

Designs, develops, and markets neurological medical devices and therapies in the United States and Europe.

Kazia Therapeutics

Market Cap: US$4.0m

Operates as an oncology-focused biotechnology company in South Korea.

Trellus Health

Market Cap: UK£3.0m

Provides digital chronic condition management solutions for employers and health plans.

ATI Physical Therapy

Market Cap: US$4.0m

Operates as an outpatient physical therapy provider that provides outpatient rehabilitation and adjacent healthcare services through its clinics in the United States.

Jaguar Health

Market Cap: US$4.0m

A commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress.